LifeStance Health Group, Inc. (LFST) Misses Q3 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
- ServiceNow (NOW) Misses Q3 EPS by 2c, Beats on Revenue; Offers Q4 Revenue Guidance
- Oracle sets $225 billion revenue target for FY30 at investor day
- Rivian shares slip ahead of Thursday earnings release
- Marvell in advanced talks to acquire Lumentum, Bloomberg reports
- SpaceX stock drops amid spaceport lawsuit, debt concerns
JPMorgan Downgrades Lifestance Health Group (LFST) to Neutral
November 9, 2021 6:59 AM ESTJPMorgan analyst Lisa Gill downgraded Lifestance Health Group (NASDAQ: LFST) from Overweight to Neutral with a price target of $12.00 (from $24.00).
The analyst comments "We are downgrading shares of LifeStance Health to Neutral from Overweight and lowering our Dec-22 price target to $12 from $24. LFST... More



